Skip to main content

Table 3 Monitoring of PPMVs in the previous six months by regulatory agencies

From: The potential role of patent and proprietary medicine vendors’ associations in improving the quality of services in Nigeria’s drug shops

  Oyo Bayelsa Total
Ibarapa East
N (%)
Kajola
N (%)
Total Brass
N (%)
Ogbia
N (%)
Total
At least one monitoring visit 38 (95.0) 39 (97.5) 77 (96.3) 32 (80.0) 23 (57.5) 55 (68.8) 132 (82.5)
By agency
 LGA PPMV association 30 (75.0) 38 (95.0) 68 (85.5) 25 (62.5) 17 (42.5) 42 (52.5) 110 (68.8)
 NAFDAC 16 (40.0) 14 (35.0) 30 (37.5) 14 (35.0) 14 (35.0) 28 (35.0) 58 (36.3)
 PCN 30 (75.0) 11 (27.5) 41 (51.3) 1 (2.5) 5 (12.5) 6 (7.5) 47 (29.4)
 NDLEA 16 (40.0) 18 (45.0) 34 (42.5) 9 (22.5) 5 (12.5) 14 (17.5) 48 (30.0)
 State PPMV association 10(25.0) 13(32.5) 23 (28.8) 2 (5.0) 2 (5.0) 4 (5.0) 27 (16.9)
 State Ministry of Health 14(35.0) 12 (30.0) 26 (32.5) 7 (17.5) 0 (0.0) 7 (8.8) 33 (20.6)
Others 13 (32.5) 14 (35.0) 27 (33.8) 1 (2.5) 2 (5.0) 3 (3.8) 30 (37.5)